CD19 and ovarian carcinoma: Notably, MSLN and CD19-CAR NK cells exhibited a negligible impact on SK-HEP-1 MSLN-negative cells, while decisively eliminating OVCAR-3 and SK-OV-3 MSLN-positive ovarian cancer cells in vitro studies.